Cargando…

Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times

Introduction: The World Health Organization declared COVID-19 a global pandemic on 03/11/20. Subsequent concerns around caring for patients with sickle cell disease who require automated red blood cell (RBC) exchange transfusions emerged, especially in the setting of physical distancing and national...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godby, Richard Curtis, Kornbrust, Ashton, Noubouossie, Denis, Lima, Jose, Marques, Marisa B., Siniard, Rance C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356310/ http://dx.doi.org/10.1182/blood-2020-142535

Ejemplares similares

Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors
por: Baez Sosa, Valentina, et al.
Publicado: (2021)

Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients
por: Sanz, Cristina, et al.
Publicado: (2020)

Transfusion with Tested Bloods
Publicado: (1918)

The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)

Further Observations on the Results of Blood Transfusion in War Surgery
Publicado: (1918)

COVID-19 Vaccination Motivation and Hesitancy in Heart Transplant Recipients During a Global Health Crisis
por: Mohney, K.L., et al.
Publicado: (2022)

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
por: Browning, Sabrina L., et al.
Publicado: (2020)

Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2
por: Pérez-Jacobo, Fernando, et al.
Publicado: (2020)

Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)

Impact of Blood Group Type on Severity of Disease in COVID-19 Patients
por: Rao, Shivani, et al.
Publicado: (2020)

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study
por: Khanna, Nina, et al.
Publicado: (2020)

Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic
por: Baez Sosa, Valentina, et al.
Publicado: (2020)

Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience.
por: Plaza, Carlos, et al.
Publicado: (2020)

COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients
por: Ibrahim, Moayed, et al.
Publicado: (2020)

Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients
por: Ramo, Aula, et al.
Publicado: (2020)

A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients
por: Al Hashmi, Hani, et al.
Publicado: (2020)

ABO/Rh Blood Group and COVID-19 Infection Severity
por: Hermel, David J, et al.
Publicado: (2020)

A Simple and Rapid Method for the Selection of Suitable Donors for Transfusion by the Determination of Blood Groups
Publicado: (1918)

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
por: Smeltzer, Matthew P, et al.
Publicado: (2021)

Effects of vaccines in patients with sickle cell disease: a systematic review protocol
por: Wiyeh, Alison Beriliy, et al.
Publicado: (2018)

Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania
por: Anie, Kofi A, et al.
Publicado: (2021)

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study
por: Tay, Jason, et al.
Publicado: (2016)

Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
por: Thom, Howard, et al.
Publicado: (2020)

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease
por: Anie, Kofi A, et al.
Publicado: (2012)

Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana
por: Anie, Kofi A, et al.
Publicado: (2017)

Iron stores in pregnant women with sickle cell disease: a protocol for a systematic review and meta-analysis
por: Aroke, Desmond, et al.
Publicado: (2019)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study
por: Zalpuri, Saurabh, et al.
Publicado: (2012)

Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study
por: Gombotz, Hans, et al.
Publicado: (2016)

Behaviour modification interventions to optimise red blood cell transfusion practices: a systematic review and meta-analysis
por: Soril, Lesley J J, et al.
Publicado: (2018)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007–2018 National Health Interview Survey (NHIS)
por: Gyamfi, Joyce, et al.
Publicado: (2023)

Efficacy and safety of pharmacological interventions for managing sickle cell disease in children and adolescents: protocol for a systematic review with network meta-analysis
por: Tonin, Fernanda S, et al.
Publicado: (2023)

Aneurysmal SubArachnoid Hemorrhage—Red Blood Cell Transfusion And Outcome (SAHaRA): a pilot randomised controlled trial protocol
por: English, Shane W, et al.
Publicado: (2016)

Systematic reviews and meta-analyses comparing mortality in restrictive and liberal haemoglobin thresholds for red cell transfusion: protocol for an overview of systematic reviews
por: Trentino, Kevin M, et al.
Publicado: (2019)

Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage
por: Uter, Stacey, et al.
Publicado: (2021)

Reticulocytes in donor blood units enhance red blood cell alloimmunization
por: Thomas, Tiffany A., et al.
Publicado: (2023)

SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt
por: Cho, Gavin, et al.
Publicado: (2016)

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia
por: Taher, Ali T, et al.
Publicado: (2023)

Changes in perioperative red cell transfusion practice over time in patients undergoing surgery for upper gastrointestinal and liver cancer: a retrospective cohort study at a single tertiary centre
por: Yee, Mei Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qqu0o1vb5ckr99ikn449145fqu